𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An evaluation of recombinant leukocyte a interferon with aspirin in patients with metastatic renal cell cancer

✍ Scribed by Edward T. Creagan; Jan C. Buckner; Richard G. Hahn; Ronald R. Richardson; Daniel J. Schaid; John S. Kovach

Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
510 KB
Volume
61
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Interferon-alpha antibodies in patients
Interferon-alpha antibodies in patients with renal cell carcinoma treated with recombinant interferon-alpha-2A in an adjuvant multicenter trial
✍ Otto PrΓΌmmer; Delta-P Study Group πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 657 KB

Background. Prolonged therapy with interferon (IFN) may lead to the formation of IFN antibodies. Methods. Patients with renal cell carcinoma (n = 270) with advanced localized disease were randomized after complete tumor resection to receive treatment with adjuvant recombinant IFN-alpha-2a (rIFN-a2a

Further experience with recombinant inte
Further experience with recombinant interferon alfa-2a with vinblastine in metastatic renal cell carcinoma: A progress report
✍ S. D. FossΓ₯; S. T. De Garis πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 French βš– 404 KB

Thirty-three patients with measurable metastatic renal cell carcinoma were entered into 2 consecutive phase II protocols using interferon alfa-2a. In protocol I, 20 patients were treated with interferon alfa-2a at a dose of 36 x I06 IU i.m. t.i.w. Vinblastine was also given t o 18 of these patients